Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Rogers Sciences Inc.
Age
0–21
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients receiving care at Shriners Hospitals for Children-Boston for a skin tissue injury.
Patients who have at least one wound with exposed area sufficient, in the Investigator's opinion, to receive LIMB therapy.
Willing and able to adhere to daily LIMB therapy protocol.
You may not be if
Patients deemed not medically stable by the treating Investigator.
Patients with clinical signs and symptoms of systemic infection at baseline.
Patients with burn wounds limited to their head and genitalia.
Patients who, in the opinion of the Investigator, will not require daily dressing changes.
Patients receiving photosensitizing agents that result in cutaneous phototoxicity prior to enrollment. Patients who have received one or more of the following photosensitizers cannot be enrolled into the study: photofrin, amiodarone, chloropromazine, fluoroquinolone antibiotics, thiazide diuretics, quinine, demethylchlortetracycline, psoralens, nalidixic acid, tetracycline, naproxen.
Patients currently enrolled or participating in another investigational device, drug or biological trial within 30 days of the Screening Visit.
Patients currently receiving any bandages or devices containing silver compounds.
Patients on a ventilator, who have fluid resuscitation or are in any terminal condition.
